Acute Liver Failure Differential Diagnoses
- Author: Gagan K Sood, MD; Chief Editor: Julian Katz, MD more...
Diagnostic Considerations
A wide variety of conditions can cause acute liver failure or produce mental status changes and coagulopathy resembling acute liver failure. Problems to consider include the following:
- Acute fatty liver of pregnancy
- Amanita phalloides mushroom poisoning
- Bacillus cereus toxin
- Fructose intolerance
- Galactosemia
- HELLP syndrome of pregnancy
- Hemorrhagic viruses (Ebola virus, Lassa virus, Marburg virus)
- Idiopathic drug reaction (hypersensitivity)
- Neonatal iron storage disease
- Tyrosinemia
- Acetaminophen poisoning
For a discussion of acute liver failure and other diagnostic considerations in liver transplant recipients, see the eMedicine article Liver Transplants.
Differential Diagnoses
- Acute decompensation of cirrhosis
- Alcoholic hepatitis with underlying cirrhosis
- Autoimmune Chronic Active Hepatitis
- Eclampsia
- Preeclampsia
- Sepsis with multiorgan failure
[Guideline] Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. May 2005;41(5):1179-97. [Medline].
Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. Nov 2004;127(5):1338-46. [Medline].
Jiang W, Desjardins P, Butterworth RF. Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. Neurochem Int. Jul-Aug 2009;55(1-3):124-8. [Medline].
Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology. Jan 1995;21(1):240-52. [Medline].
Lee WM, Schiodt FV. Fulminant hepatic failure. In: Schiff ER, Sorrell, MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 8th ed. Baltimore: Md: Lippincott Williams & Wilkins; 1999.
Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. Jul 1992;16(1):1-7. [Medline].
Detry O, Arkadopoulos N, Ting P, Kahaku E, Margulies J, Arnaout W, et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation. Mar 15 1999;67(5):767-70. [Medline].
Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med. Oct 16 1997;337(16):1112-7. [Medline].
Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. Dec 2005;42(6):1364-72. [Medline].
Davern TJ 2nd, James LP, Hinson JA, Polson J, Larson AM, Fontana RJ, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology. Mar 2006;130(3):687-94. [Medline].
Khandelwal N, James LP, Sanders C, Larson AM, Lee WM. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology. Feb 2011;53(2):567-76. [Medline].
Klein AS, Hart J, Brems JJ, Goldstein L, Lewin K, Busuttil RW. Amanita poisoning: treatment and the role of liver transplantation. Am J Med. Feb 1989;86(2):187-93. [Medline].
Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. Nov 2007;35(11):2498-508. [Medline].
O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. Aug 1989;97(2):439-45. [Medline].
Lee WM, Galbraith RM, Watt GH, Hughes RD, McIntire DD, Hoffman BJ, et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology. Jan 1995;21(1):101-5. [Medline].
Schiødt FV, Rossaro L, Stravitz RT, Shakil AO, Chung RT, Lee WM. Gc-globulin and prognosis in acute liver failure. Liver Transpl. Oct 2005;11(10):1223-7. [Medline].
Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. Jan 1991;12(1):1-9. [Medline].
Bernal W. Intensive care support therapy. Liver Transpl. Sep 2003;9(9):S15-7. [Medline].
Jalan R. Acute liver failure: current management and future prospects. J Hepatol. 2005;42 Suppl(1):S115-23. [Medline].
Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. Feb 2004;39(2):464-70. [Medline].
Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis. Nov 1996;16(4):403-14. [Medline].
[Guideline] Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. Jun 2005;41(6):1407-32. [Medline].
AASLD position paper: the management of acute liver failure. Private Nonprofit Research Organization. American Association for the Study of Liver Diseases - Private Nonprofit Research Organization. May 2005;36(1):19 pages.
Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs. May 1994;18(5):390-6. [Medline].
Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis. Nov 1996;16(4):435-44. [Medline].
Nyberg SL, Misra SP. Hepatocyte liver-assist systems--a clinical update. Mayo Clin Proc. Aug 1998;73(8):765-71. [Medline].
Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. May 2004;239(5):660-7; discussion 667-70. [Medline]. [Full Text].
ClinicalTrials.gov. The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure. Available at http://clinicaltrials.gov/ct2/show/NCT00655304.
| Grade | Level of Consciousness | Personality and Intellect | Neurologic Signs | Electroencephalogram (EEG) Abnormalities |
| 0 | Normal | Normal | None | None |
| Subclinical | Normal | Normal | Abnormalities only on psychometric testing | None |
| 1 | Day/night sleep reversal, restlessness | Forgetfulness, mild confusion, agitation, irritability | Tremor, apraxia, incoordination, impaired handwriting | Triphasic waves (5 Hz) |
| 2 | Lethargy, slowed responses | Disorientation to time, loss of inhibition, inappropriate behavior | Asterixis, dysarthria, ataxia, hypoactive reflexes | Triphasic waves (5 Hz) |
| 3 | Somnolence, confusion | Disorientation to place, aggressive behavior | Asterixis, muscular rigidity, Babinski signs, hyperactive reflexes | Triphasic waves (5 Hz) |
| 4 | Coma | None | Decerebration | Delta/slow wave activity |

